modulators, receptor internalization, and navigating the transition from academic GPCR research to biotech She now works at Gator Bio, where she transitioned from Field Application Scientist - serving as a technical constraint on pharmacological interpretation Equilibrium vs. dynamic frameworks for studying receptor biology An assay measures a specific thing - not the biology you assume it measures One of Livingston's most Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief Nicholas Holliday on the web LinkedIn ORCID University of Nottingham Twitter Excellerate Bio Dr.

Not OK to use: Advertising Spam Anything misleading or annoying Social media bios Paying or offering

You’ll be asked for: Instructor info – name, email, affiliation, short bio, photo, and optional social

This conversation covers thermostabilization, cryoEM, and GPCR structural biology. << Back to podcast list Strategic Partner(s) Chris Tate: Thermostabilizing GPCRs for Structural Biology For most of the 1990s and early 2000s, GPCR structural biology was not a biology problem - it was a stability problem ABOUT THE GUEST Chris Tate is a group leader at the MRC Laboratory of Molecular Biology in Cambridge, UK, where his research focuses on the structural and biochemical study of membrane proteins, with particular

to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists CSO of Celtarys Research, shares the story behind the company’s journey from academic curiosity to biotech When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap That changed with support from Galicia’s robust biotech network, and the company quickly defined its It’s about enabling biology.” — Maria Majellaro Through its partnership with Dr.

Joseph Kim exploring GPCR structural biology, cryo-electron microscopy, opioid receptor pharmacology, like the galanin receptor family. << Back to podcast list Strategic Partner(s) Joseph Kim: Structural Biology Joseph Kim discusses the intersection of structural biology, membrane protein biochemistry, and drug Joseph Kim is a structural biologist studying membrane proteins and GPCR pharmacology. His work combines structural biology, membrane protein biochemistry, and pharmacological insights to

Transform your biotech idea or data into a clear, strategic roadmap with aligned biology, timelines, Home About Services News Get in Touch Welcome Biotech Growth Wherever You Are in Discovery—Let’s Build a Plan That Moves You Forward Align your biology, timeline and CRO roadmap. Biotech teams often tell me: “We have too many CROs and not enough clarity.” We'll define what matters, when to decide, and how to act—based on your biology, not just what's easy

Eurofins DiscoverX scientists on physiological relevance, the GPCRs that refuse to work, and why obesity biology list Strategic Partner(s) Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays That Reflect Real Biology Obesity and GLP-1 biology changed that, and the largest target class is once again at the front of drug and biosimilars, keeping him in close contact with the scientists running these assays day to day. The easy readout drifts away from the biology researchers actually want to measure.

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists Riccardo Capelli is an assistant professor in Applied Physics at the Department of Biosciences, University methods such as structure-based models and enhanced sampling techniques, as well as their application to biomolecular ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter X : @ ric_capelli Computational Structural Biology

GPCR — Scaling Biotech Beyond the Bench Turning scientific excellence into scalable organizations. Leadership 👉 Ambition is the default setting of biotech. This is the hidden cost of ambition in biotech leadership. Not failure. Not poo Attila Foris Mar 2 The Real Cost of Strategic Overload in Biotech 👉 In early-stage biotech, At the same time, the team is preparing for biotech fundraising.

Beyond screening, our capabilities include custom assay development, deorphanization, biophysical characterization Combined with high-throughput execution and rapid turnaround times, we help generate the biologically Mechanistic pharmacology studies Custom assay solutions Translational & advanced cell models Cell-based and biochemical View Biophysics Biophysical characterization for mechanistic, structure-informed insight. View Advanced Pharmacology & Translational Models Advanced pharmacology and translational models for biologically

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

tissue-specific engagement Who should listen Navigated complex datasets where interpretation depended on biological His group develops imaging and chemical biology tools to reveal how GLP-1 and GIP receptors operate within David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Unlock

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

not just sequence matches — is non-trivial, and it matters for anyone hoping to translate kidney OR biology She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before She received her undergraduate degree in Biotechnology from KIIT University in India. Monserrat Avila Zozaya I did a PhD in cell biology at CINVESTAV, Mexico. About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Biology his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical and biotech

underappreciated axis of pharmacological modulation, and long-running collaborations on beta-adrenergic receptor biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

chemists, systems biologists, structural biologists, and drug-discovery veterans — drew on their combined Yaroslav Nikolaev is a scientist at InterAx Biotech with a dual background in biology and computation His research combines biomolecular NMR, structural biology, and machine learning to study how GPCRs function True negatives quietly wreck biological models. The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide

Silvia Sposini " I'm originally from Rome, Italy, where I studied Biological Sciences as a BSc student

Key Takeaways: From Protein Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. Dmitry studied biophysics at the Moscow State University, followed by a PhD (1998) in protein folding He joined the MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology

Claudia Stäubert "I received my degree in biochemistry from Leipzig University (Germany) being already Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn

This conversation covers what it looks like to do receptor biology when you are writing the first chapter She trained in protein biochemistry and neuroscience, completing her PhD in Germany and her postdoctoral Since returning to Europe, her research has centered on receptor biology at the intersection of basic It is a small detail, but it marks something real about the state of adhesion GPCR biology in insects : these receptors exist in a space where the biology precedes the vocabulary.

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in Originally from Łódź, Poland, Jacek completed his Master's degree in Biology, specializing in Biochemistry

How GPCR genetic variants shape psychiatric drug response - Hauser on pharmacogenomics, the iPSYCH biobank To answer this, his work integrates GPCR molecular pharmacology with computational biology, population genetics, and pharmacoepidemiology, drawing on Denmark's iPSYCH biobank - a cohort of 100,000 genotyped Psychiatry in Roskilde working with the UK Biobank and other large-scale population cohorts. Alexander has a big interest in the integration of large biomedical data in genomics, structural biology

neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics, a biotech Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery biology.

Gloriam on orphan GPCR biology, GPCRDB, biased signaling, and how the data analysis bottleneck is reshaping This conversation explores the intersection of computational biology, cheminformatics, and structural research group working across data science, computational drug design, pharmacology, and structural biology His primary research focus is orphan GPCR biology, with particular emphasis on identifying endogenous for experimentalists, but as the primary constraint to overcome in advancing receptor biology.

The work connects receptor biology to neuropsychiatric disease: addiction, autism spectrum disorder, About the Guest Antony Boucard is a biochemist and cell biologist who leads the Boucard Laboratory at frontier, where the biology is catching up to the structural classification. 2. That gap is where the most important biology is happening. 6. , cell biology, and translational thinking could do something that wasn't already being done.

Structural biologist Qing Fan describes a decade of GABA-B receptor research at Columbia - from obligate ABOUT THE GUEST Qing Fan is an associate professor of pharmacology and pathology and cell biology at A structural biologist by training, her research focuses on the three-dimensional architecture of class cross-disciplinary collaboration, to connect structural findings to receptor function and disease-relevant biology Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit